and also an inhibition that occurred after removal of the steroid and was maximal 90 min after its introduction (early delayed inhibition).
INTRODUCTION
The secretion of adrenocorticotrophin (ACTH) from the anterior pituitary gland is partly regulated by inhibitory feedback from circulating glucocorticoids produced by the adrenal cortex. This negative feed¬ back mechanism has two distinct elements, character¬ ized by the time-domain in which they are effective.
The first of these, termed fast feedback inhibition, occurs rapidly (within seconds or a few minutes), its magnitude being proportional to the rate of rise of glucocorticoid concentration in the blood. The second is evident only later (after many minutes or hours), when plasma concentrations of corticoids are falling, or may even have returned to baseline values, and is referred to as 'delayed feedback' (Dallman & Yates, 1969; Jones, Brush & Neame, 1972) . Delayed feed¬ back can be further subdivided into early and late phases (Dallman, 1979) . Possessing an even more pro¬ tracted time-course is the inhibition of the activity of the hypothalamo-pituitary-adrenocortical axis which is evident after chronic administration (days or weeks) of glucocorticoids (Buckingham & Hodges, 19770; Nicholson, Campbell, Torrellas et al. 1984; Nicholson, Campbell, Gillham & Jones, 1987) . Inhibition by glucocorticoids ofthe release ofACTH in all three timedomains (fast, delayed and chronic feedback) can be demonstrated using the rat anterior pituitary gland incubated in vitro and exposed to various ACTH secretagogues (Mahmoud, Scaccianoce, Scraggs et al. 1984; Nicholson et al. 1987) , although with the limitation that this preparation does not seem to exhibit exactly the characteristics of fast feedback seen in vivo (Mahmoud et al. 1984) .
Chronic glucocorticoid treatment of the rat, whilst profoundly suppressing the release of ACTH from the anterior pituitary gland in response to secretagogues added in vitro, has no inhibitory effect on the enhanced accumulation of intracellular cyclic AMP (cAMP) induced by addition of corticotrophin-releasing factor (CRF-41), or on that of inositol phosphates by argi¬ nine vasopressin (AVP) (Nicholson, Gillham & Jones, 1988) . The purpose of this study was Exposure of the tissue to dexamethasone for 5 min before and during the addition of the CRF-41 (fast feedback signal) produced a significant (P<0-01) inhibition of stimulated ACTH release, whilst having no effect on basal output (Fig. 2a) . In contrast, the same protocol of steroid treatment shifted the doseresponse curve for the production of cAMP by CRF- (Fig. 3a) . In this case, the cAMP response to subsequently added CRF-41 was unaffected by dexamethasone ( Fig. 3b; There was significant (P<001) but partial inhibi¬ tion of the inositol phosphate response to the higher concentration of AVP (3000 nmol/1) used by the fast feedback signal, but no effect on the enhanced accumulation induced by the lower (Fig. 4b) . Doseresponse relationships for inositol phosphate accumu¬ lation induced by AVP were similar whether or not the pituitary tissues had been exposed to a delayedfeedback signal (Fig. 5b) . (Quelle, Smith, Hrycyna et al. 1988) .
Interpretation of the data concerning the influence of dexamethasone, acting in the fast feedback domain, on the AVP-induced changes in inositol phosphate accumulation is rather more difficult, largely because from a functional point of view it seems that corti¬ cotrophs express two types of AVP receptors (Buckingham, 1986) , perhaps in two subtypes of cells (Schwarz & Vale, 1988) . Normal V, receptors seem to mediate the ability of high concentrations (of the order of 1 pmol/1) of the peptide to cause the release of ACTH when acting alone (Buckingham, 1986) and this receptor has been shown to be coupled to the acti¬ vation of phospholipase C specific for phosphatidyl inositol phosphates (Todd & Lightman, 1987) . The second vasopressin receptor type found in the anterior pituitary gland seems to differ from both V, and V2 (cAMP-coupled) receptors (Baertschi & Friedli, 1985; Knepel, Götz & Fahrenholz, 1986 (Gillies, Linton & Lowry, 1982; Buckingham, 1986 (Buckingham, 1979) . These findings suggest that neither adenylate cyclase nor phospholipase C are targets for inhibition by gluco¬ corticoids during early delayed feedback, a conclusion also drawn by Giguere, Labrie, Cote et al. (1982) (Eberwine & Roberts, 1984) , a significant reduction in the total mRNA pool is only seen 6 h after glucocorticoid is added. However, this conclu¬ sion would be invalidated if it were proved that there were a small 'translationally privileged pool' of mRNA for POMC.
The findings of the present study suggest that a search for a non-genomic mechanism whereby gluco¬ corticoids act rapidly to attenuate second messenger responses in corticotrophs would be profitable.
